• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组水疱性口炎病毒载体在非人灵长类动物中的神经毒力特性

Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.

作者信息

Johnson J Erik, Nasar Farooq, Coleman John W, Price Roger E, Javadian Ali, Draper Kenneth, Lee Margaret, Reilly Patricia A, Clarke David K, Hendry R Michael, Udem Stephen A

机构信息

Wyeth Vaccines Research, 401 N. Middletown Road, Pearl River, NY 10965, USA.

出版信息

Virology. 2007 Mar 30;360(1):36-49. doi: 10.1016/j.virol.2006.10.026. Epub 2006 Nov 13.

DOI:10.1016/j.virol.2006.10.026
PMID:17098273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1865117/
Abstract

Although vesicular stomatitis virus (VSV) neurovirulence and pathogenicity in rodents have been well studied, little is known about VSV pathogenicity in non-human primates. To address this question, we measured VSV viremia, shedding, and neurovirulence in macaques. Following intranasal inoculation, macaques shed minimal recombinant VSV (rVSV) in nasal washes for 1 day post-inoculation; viremia was not detected. Following intranasal inoculation of macaques, wild type (wt) VSV, rVSV, and two rVSV-HIV vectors showed no evidence of spread to CNS tissues. However, macaques inoculated intrathalamically with wt VSV developed severe neurological disease. One of four macaques receiving rVSV developed clinical and histological signs similar to the wt group, while the remaining three macaques in this group and all of the macaques in the rVSV-HIV vector groups showed no clinical signs of disease and reduced severity of histopathology compared to the wt group. The implications of these findings for rVSV vaccine development are discussed.

摘要

尽管水泡性口炎病毒(VSV)在啮齿动物中的神经毒性和致病性已得到充分研究,但对于VSV在非人类灵长类动物中的致病性却知之甚少。为了解决这个问题,我们测量了猕猴体内的VSV病毒血症、排毒情况和神经毒性。经鼻内接种后,猕猴在接种后1天的鼻腔冲洗液中排出的重组VSV(rVSV)极少;未检测到病毒血症。经鼻内接种猕猴后,野生型(wt)VSV、rVSV和两种rVSV-HIV载体均未显示扩散至中枢神经系统组织的迹象。然而,经丘脑内接种wt VSV的猕猴出现了严重的神经疾病。接受rVSV的四只猕猴中有一只出现了与wt组相似的临床和组织学症状,而该组其余三只猕猴以及rVSV-HIV载体组的所有猕猴均未出现疾病的临床症状,并且与wt组相比,组织病理学严重程度有所降低。本文讨论了这些发现对rVSV疫苗开发的意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/72a7885240d9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/fd9e3fd62cae/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/f1f4e420e06a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/72a7885240d9/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/fd9e3fd62cae/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/f1f4e420e06a/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a90a/7103296/72a7885240d9/gr3_lrg.jpg

相似文献

1
Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates.重组水疱性口炎病毒载体在非人灵长类动物中的神经毒力特性
Virology. 2007 Mar 30;360(1):36-49. doi: 10.1016/j.virol.2006.10.026. Epub 2006 Nov 13.
2
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates.表达丝状病毒糖蛋白的重组水疱性口炎病毒疫苗载体在非人灵长类动物中缺乏神经毒力。
PLoS Negl Trop Dis. 2012;6(3):e1567. doi: 10.1371/journal.pntd.0001567. Epub 2012 Mar 20.
3
Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.感染M蛋白突变型水疱性口炎病毒的小鼠在无神经毒力情况下的免疫反应
J Virol. 2008 Sep;82(18):9273-7. doi: 10.1128/JVI.00915-08. Epub 2008 Jul 9.
4
Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice.通过基因易位和g基因截短对重组水疱性口炎病毒-1型人类免疫缺陷病毒疫苗载体进行减毒,可降低神经毒性并增强小鼠的免疫原性。
J Virol. 2008 Jan;82(1):207-19. doi: 10.1128/JVI.01515-07. Epub 2007 Oct 17.
5
Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag.用于同时检测水疱性口炎病毒印第安纳血清型和HIV gag的定量多重检测法。
J Virol Methods. 2007 Jul;143(1):55-64. doi: 10.1016/j.jviromet.2007.02.007. Epub 2007 Mar 26.
6
Live virus vaccines based on a vesicular stomatitis virus (VSV) backbone: Standardized template with key considerations for a risk/benefit assessment.基于水疱性口炎病毒(VSV)骨架的活病毒疫苗:风险/收益评估关键考量的标准化模板
Vaccine. 2016 Dec 12;34(51):6597-6609. doi: 10.1016/j.vaccine.2016.06.071. Epub 2016 Jul 6.
7
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector.重组水疱性口炎病毒作为一种HIV-1疫苗载体。
Springer Semin Immunopathol. 2006 Nov;28(3):239-53. doi: 10.1007/s00281-006-0042-3. Epub 2006 Sep 15.
8
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.一种新型嵌合溶瘤病毒载体,可提高安全性和疗效,作为治疗肝细胞癌的平台。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01386-18. Print 2018 Dec 1.
9
mRNA cap methylation influences pathogenesis of vesicular stomatitis virus in vivo.信使核糖核酸帽甲基化影响水疱性口炎病毒在体内的发病机制。
J Virol. 2014 Mar;88(5):2913-26. doi: 10.1128/JVI.03420-13. Epub 2013 Dec 26.
10
Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations.特定G基因截短与N基因易位联合对水疱性口炎病毒的协同减弱作用。
J Virol. 2007 Feb;81(4):2056-64. doi: 10.1128/JVI.01911-06. Epub 2006 Dec 6.

引用本文的文献

1
Shaping viral immunotherapy towards cancer-targeted immunological cell death.将病毒免疫疗法导向癌症靶向性免疫细胞死亡。
Front Oncol. 2025 Jul 8;15:1540397. doi: 10.3389/fonc.2025.1540397. eCollection 2025.
2
Recombinant VSVs: A Promising Tool for Virotherapy.重组水泡性口炎病毒:病毒疗法的一种有前景的工具。
Acta Naturae. 2024 Oct-Dec;16(4):4-14. doi: 10.32607/actanaturae.27501.
3
Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations.溶瘤性水疱性口炎病毒在癌症病毒治疗中的应用:耐药性及临床考量

本文引用的文献

1
Vesicular stomatitis in cattle and horses in Colorado.科罗拉多州牛和马的水疱性口炎
North Am Vet. 1945 Dec;26:726-30.
2
INFLUENCE OF HOST FACTORS ON NEUROINVASIVENESS OF VESICULAR STOMATITIS VIRUS : I. EFFECT OF AGE ON THE INVASION OF THE BRAIN BY VIRUS INSTILLED IN THE NOSE.宿主因素对水泡性口炎病毒神经侵袭性的影响:I. 年龄对病毒经鼻腔接种后入侵大脑的影响。
J Exp Med. 1937 Jun 30;66(1):15-34. doi: 10.1084/jem.66.1.15.
3
COMPARATIVE STUDIES ON THE VIRUSES OF VESICULAR STOMATITIS AND EQUINE ENCEPHALOMYELITIS (1).口蹄疫病毒与马传染性脑脊髓炎病毒的比较研究(1)。
Viruses. 2024 Dec 25;17(1):16. doi: 10.3390/v17010016.
4
Safety, Immunogenicity, and Efficacy of a Recombinant Vesicular Stomatitis Virus Vectored Vaccine Against Severe Fever with Thrombocytopenia Syndrome Virus and Heartland Bandavirus.一种重组水疱性口炎病毒载体疫苗针对严重发热伴血小板减少综合征病毒和哈特兰病毒的安全性、免疫原性及有效性
Vaccines (Basel). 2024 Dec 12;12(12):1403. doi: 10.3390/vaccines12121403.
5
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer.复发性乳腺癌新辅助溶瘤病毒疗法的非常规病例研究
Vaccines (Basel). 2024 Aug 23;12(9):958. doi: 10.3390/vaccines12090958.
6
Multi-modal efficacy of a chimeric vesiculovirus expressing the Morreton glycoprotein in sarcoma.表达莫雷顿糖蛋白的嵌合水疱性口炎病毒在肉瘤中的多模态疗效
Mol Ther Oncolytics. 2023 Mar 1;29:4-14. doi: 10.1016/j.omto.2023.02.009. eCollection 2023 Jun 15.
7
Pharmacokinetics and biodistribution of extracellular vesicles administered intravenously and intranasally to .静脉内和鼻内给予的细胞外囊泡的药代动力学和生物分布。 (注:原文句末不完整,翻译根据现有内容尽量完整呈现)
J Extracell Biol. 2022 Oct;1(10). doi: 10.1002/jex2.59. Epub 2022 Oct 11.
8
Vesicular Stomatitis Virus Isolated from a Bovine Brain Sample in Costa Rica.从哥斯达黎加一份牛脑样本中分离出的水疱性口炎病毒。
Microbiol Resour Announc. 2022 Oct 20;11(10):e0073722. doi: 10.1128/mra.00737-22. Epub 2022 Sep 20.
9
Drosophila as a Model for Human Viral Neuroinfections.果蝇作为人类病毒神经感染模型。
Cells. 2022 Aug 29;11(17):2685. doi: 10.3390/cells11172685.
10
Recombinant vesicular stomatitis vaccine against Nipah virus has a favorable safety profile: Model for assessment of live vaccines with neurotropic potential.重组水疱性口炎病毒抗尼帕病毒疫苗具有良好的安全性:用于评估具有神经嗜性潜力的活疫苗的模型。
PLoS Pathog. 2022 Jun 27;18(6):e1010658. doi: 10.1371/journal.ppat.1010658. eCollection 2022 Jun.
J Exp Med. 1934 Jan 31;59(2):159-71. doi: 10.1084/jem.59.2.159.
4
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector.重组水疱性口炎病毒作为一种HIV-1疫苗载体。
Springer Semin Immunopathol. 2006 Nov;28(3):239-53. doi: 10.1007/s00281-006-0042-3. Epub 2006 Sep 15.
5
Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus.用表达白细胞介素-12和猿猴免疫缺陷病毒gag的质粒DNA进行预刺激,可增强基于重组水疱性口炎病毒的实验性艾滋病疫苗的免疫原性和效力。
AIDS Res Hum Retroviruses. 2005 Jul;21(7):629-43. doi: 10.1089/aid.2005.21.629.
6
Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine.基于减毒水泡性口炎病毒(VSV)的疫苗单次免疫可提供对严重急性呼吸综合征冠状病毒(SARS-CoV)感染的长期保护。
Virology. 2005 Sep 30;340(2):174-82. doi: 10.1016/j.virol.2005.06.016.
7
Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.减毒活重组疫苗可保护非人灵长类动物免受埃博拉病毒和马尔堡病毒感染。
Nat Med. 2005 Jul;11(7):786-90. doi: 10.1038/nm1258. Epub 2005 Jun 5.
8
Chandipura virus, encephalitis, and epidemic brain attack in India.钱迪普拉病毒、脑炎与印度的流行性脑猝病
Lancet. 2004;364(9452):2175; author reply 2175-6. doi: 10.1016/S0140-6736(04)17579-X.
9
Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes.表达1型人类免疫缺陷病毒包膜蛋白和猴免疫缺陷病毒群特异性抗原蛋白的减毒水疱性口炎病毒载体的免疫原性:鼻内接种和肌肉内接种途径的比较
AIDS Res Hum Retroviruses. 2004 Sep;20(9):989-1004. doi: 10.1089/aid.2004.20.989.
10
A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus.2003年,印度安得拉邦发生了一起儿童急性脑炎大爆发,死亡率很高,这与钱迪普拉病毒有关。
Lancet. 2004;364(9437):869-74. doi: 10.1016/S0140-6736(04)16982-1.